Press Release Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules Business Wire · Sep 15
Press Release Morningstar Says “Game On” to Helping Investors Make Sense of the Public-Private Market Reality Business Wire · Sep 15
Press Release Planted Raises $31.8 Million to Accelerate Autonomous Power Deployment Business Wire · Sep 15
Press Release Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease Business Wire · Sep 15
Press Release Syntis Bio Reports Phase 1/1b Results Demonstrating Weight-Loss and Satiety Hormone Modulation with Oral SYNT-101 in Patients with Obesity Business Wire · Sep 15
Press Release Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain Business Wire · Sep 15
Press Release Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes Business Wire · Sep 15
Press Release Neuberger and KKR to Invest in Datavant Alongside New Mountain Capital Business Wire · Sep 15
Press Release Xtremis Wins Defense Innovation Unit’s Spectrum Strike Prize Challenge Xtremis · Sep 15
Press Release V2X Awarded Position on $46 Million U.S. Air Force Contract Supporting B-52 Long Range Standoff Cruise Missile Program V2X, Inc. · Sep 15